Clinical Trial Update: Molecular Monitoring With Circulating Tumor DNA and Nivolumab Maintenance [EARLY_Phase 1]

View source ↗

Summary

This update covers an early-phase trial evaluating circulating tumor DNA monitoring and nivolumab maintenance in Diffuse Large B-Cell Lymphoma that has complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• nivolumab (nivolumab)

Snippet

Sponsor: Fox Chase Cancer Center | Conditions: Diffuse Large B Cell Lymphoma | EARLY_Phase 1 | Status: COMPLETED